STEVENS JENNIFER (Chief Regulatory Officer) sold 2.8% of their position (3.53K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market sale worth $14.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/20/2026ACC: 0001628280-26-020187
Officer· Chief Regulatory Officer
Since Aug 2023
-3.53K
Net shares
Net seller
$14.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3.53K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.20K
Price / share
$4.13
Trade value
$4.97K
% of position
0.9%
3/11/2026
127.64K→126.44K
Common Stock
Direct
Shares
−1.55K
Price / share
$4.09
Trade value
$6.35K
% of position
1.2%
3/12/2026
126.44K→124.88K
Common Stock
Direct
Shares
−774.00
Price / share
$4.12
Trade value
$3.19K
% of position
0.6%
3/16/2026
124.88K→124.11K
Total
Net shares
−3.53K
Net value
-$14.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −1.20K | $4.13 | $4.97K | 0.9% | 127.64K | 126.44K |
| Common Stock Direct | 3/12/2026 | S · Sale | −1.55K | $4.09 | $6.35K | 1.2% | 126.44K | 124.88K |
| Common Stock Direct | 3/16/2026 | S · Sale | −774.00 | $4.12 | $3.19K | 0.6% | 124.88K | 124.11K |
| Total | −3.53K | -$14.51K | ||||||
Derivative Transactions0
No derivative transactions reported